Impaired expression of CD28 on T cells in hairy cell leukemia

Clinical Immunology

Volumn 93, Issue 3, 1999, Pages 256-262

  Van De Corput, L ^a   Falkenburg, J H F ^a   Kester, M G D ^a   Willemze, R ^a   Kluin Nelemans, J C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD28; Hairy cell leukemia; Mixed lymphocyte culture; T cells

Indexed keywords

CD28 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MIXED LEUKOCYTE CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032787093     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4794     Document Type: Article

References (40)

1. Cawley J. C., Burns G. F., Hayhoe F. J. G. Hairy Cell Leukemia. 1980;Springer Verlag, Berlin. p. 85-86.
2. Kluin-Nelemans J. C. Hairy cell leukemia ant its T cell interactions. Leukocyte Lymphoma. 4:1991;159-166.
3. Knight R. A., Worman C. P., Cawley J. C. Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukemia. Clin. Exp. Immunol. 53:1983;600-604.
4. Janeway C. A., Bottomly K. Signals and signs for lymphocyte responses. Cell. 76:1994;275-285.
5. +) in hairy cell leukemia. Leukemia. 7:1993;46-50.
6. Lindemann A., Ludwig W. D., Oster W., Mertelsmann R., Hermann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood. 73:1989;880-884.
7. Buck C., Digel W., Schoniger W., Stefanic M., Rachavachar A., Porzsolt F. Tumor necrosis factor-alpha and hairy cell leukemia. Lancet. 2:1988;402-406.
8. Kluin-Nelemans J. C., Kester M. G. D., Oving I., Cluitmans F. H. M., Willemze R., Falkenburg J. H. F. Abnormally activated T lymphocytes in the spleen of patients with hairy cell leukemia. Leukemia. 8:1994;2095-2101.
9. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:1993;4754-4765.
10. Taga K., Mostowski H., Tosato G. Human interleukin-10 can directly inhibit T cell growth. Blood. 81:1993;2964-2971.
11. + T cells. J. Exp. Med. 184:1996;19-29.
12. Kluin-Nelemans J. C., Kester M. G. D., Corput van de L., Boor P. P. C., Landegent J. E., Dongen van J. J. M., Willemze R., Falkenburg J. H. F. Correction of abnormal T cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood. 91:1998;4224-4231.
13. Harding F. A., Mc Arthur J. G., Gross J. A., Raulet D. H., Allison J. P. CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature. 356:1992;607-609.
14. Lenschow D. J., Walunas T. L., Bluestone J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
15. Clark E. A., Ledbetter J. A. How B and T cells talk to each other. Nature. 367:1994;425-428.
16. Dutra W. O., Martins-Filho O. A., Cancado J. R., Pinto-Dias J. C., Brener Z., Gazzinelli G., Carvalho J. F., Colley D. G. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand. J. Immunol. 43:1996;88-93.
17. - T lymphocytes. J. Immunol. 150:1993;1147-1159.
18. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
19. Klaus S. J., Pinchuk L. M., Ochs H. D., Law C-L., Fanslow W. C., Armitage R. J., Clark E. A. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:1994;5643-5652.
20. Siefken R., Kurrle R., Schwinzer R. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex. Cell. Immunol. 176:1997;59-65.
21. Terstappen L. W. M. M., Shah V. O., Conrad M. P., Recktenwald D., Loken M. R. Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry. 9:1988;477-484.
22. Kluin-Nelemans J. C., Kester M. G. D., Melenhorst J. J., Landegent J. E., Corput van de L., Willemze R., Falkenburg J. H. F. Persistent clonal excess and skewed T cell repertoire in T cells from patients with hairy cell leukemia. Blood. 87:1996;3795-3802.
23. + subsets of T lymphocytes in monozygotic twins. J. Immunol. 150:1993;2033-2045.
24. Struyk L., Kurnick J. T., Hawes G. E., Laar van J. M., Schipper R., Oksenberg J. R., Steinman L., Vries de R. R., Breedveld P. C., Elsen van den P. T cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum. Immunol. 37:1993;237-251.
25. + cells expressing Vγ9Vδ2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia. Leukemia. 11:1997;106-109.
26. Green J. M., Noel P. J., Sperling A. I., Walunas T. L., Gray G. S., Bluestone J. A., Thompson G. B. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:1994;501-508.
27. Lucas P. J., Negishi I., Nakayama K-I., Fields L. E., Loh D. Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:1995;5757-5768.
28. Zhang Y-Q., Neerven van R. J. J., Van Gool S. W., Coorevits L., Boer de M., Ceuppens J. L. B7-CD28 interaction is a late acting co-stimulatory signal for human T responses. Int. Immunol. 9:1997;1095-1102.
29. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97:1996;2027-2037.
30. Sfikakis P. P., Zografou A., Viglis V., Iniotaki-Theodoraki A., Piskontaki I., Tsokos G. C., Sfikakis P., Choremi-Papadopoulou H. CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis. Arthritis Rheum. 38:1995;649-654.
31. - T cells. Eur. J. Immunol. 27:1997;1082-1090.
32. + T cells in severe rheumatoid arthritis. Arthritis Rheum. 40:1997;1106-1114.
33. - cell population in the blood and lung of HIV-positive patients. J. Acquir. Immune Defic. Syndr. 6:1993;1194-1204.
34. + lymphocytes during HIV infections. Scand. J. Immunol. 40:1994;485-490.
35. -e T cells. AIDS. 8:1994;431-441.
36. + T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7:1994;245-253.
37. + T cells from HIV-infected subjects. Clin. Exp. Immunol. 100:1995;425-433.
38. Rossi E., Matutes E., Morilla R., Owusu-Ankoma K., Heffernan A. M., Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia. 10:1996;494-497.
39. + T cells in patients with multiple myeloma and paraproteinemia. Blood. 87:1996;3297-3306.
40. + cells with a limited alloreactive T cell receptor repertoire. J. Immunol. 143:1989;2783-2789.